Status report

Get it in writing

The official USPTO status record for FALCON, serial 99614718, as a dated PDF. One price, one document, delivered in about a minute.

INSTANT DELIVERY

Trademark Status Report

$7.99

The USPTO's own status record for this mark, on one dated page.

  • Current status with a plain-English verdict
  • Owner, classes, filing basis, and every key date
  • The mark as it appears on the federal record
  • Every prosecution event, filing to today
  • Source-cited with the exact retrieval date

Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.

Payments launch soon. Leave your email and we'll tell you when this report is available.

Searching stays free, no account, no caps.

Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
FALCON
Serial 99614718 · Principal Register
Dead · Refused

Owner: Novartis AG
Class 005 - Pharmaceuticals
Filed Jan 26, 2026

The record shows that the “FALCON” application filed by Novartis AG (an Aktiengesellschaft organized in Switzerland) is dead – it was abandoned on June 25 2026 after the applicant failed to respond to an Office action, and the mark never entered the register. The filing covered only Class 005 pharmaceuticals, listing anti‑infectives, anti‑inflammatories, antibiotics, antivirals, cardiovascular and dermatological medicines, inhaled preparations for respiratory disease, central‑nervous‑system drugs and a host of other therapeutic categories. Because the claim is limited to those pharmaceutical goods, a similar name used for anything outside that scope would present the closest record‑based concern in the drug and medical‑product arena, but the record does not give Novartis control over every possible use of the word “FALCON.” The prosecution history shows the usual sequence of examiner assignment, a non‑final action in March 2026 and the abandonment notice in June 2026, with no oppositions, cancellations or court actions noted. I'd treat this as a meaningful concern if you plan a pharma‑related brand, but the risk drops sharply for unrelated goods or services.

Full event history, owner details, and verdict inside.

The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search